Acne Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Report Summary

GlobalData, the industry analysis specialist, has released its new report, “Acne Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global Acne Therapeutics market. The report identifies the key trends shaping and driving the global Acne Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Acne Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

The report provides information on the key drivers and challenges of the Acne Therapeutics market. Its scope includes -

• Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Acne Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2017.
• Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
• Analysis of the current and future competition in the seven key countries Acne Therapeutics market.
• Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
• Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Acne Therapeutics market.
• Analysis of key recent licensing and partnership agreements in Acne Therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the global Acne Therapeutics market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Acne Therapeutics market in future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
• What’s the next big thing in the global Acne Therapeutics market landscape? - Identify, understand and capitalize.

Table of Contents

1 Table of contents
1.1 List of Tables
1.2 List of Figures

2 Acne Therapeutics - Introduction
2.1 Disease Overview
2.2 Epidemiology
2.3 Etiology and Pathophysiology
2.3.1 Etiology of Acne
2.3.2 Pathophysiology of Acne
2.4 Signs and Symptoms
2.5 Diagnosis
2.6 Treatment and Management Options
2.6.1 Topical Antibiotics
2.6.2 Oral Antibiotics
2.6.3 Topical Retinoids
2.7 GlobalData Pipeline Report Guidance

3 Acne Therapeutics - Market Characterization
3.1 Acne Therapeutics Market Size (2005-2010) - Global
3.2 Acne Therapeutics Market Forecast (2010-2018) - Global
3.3 Acne Therapeutics Market Size (2005-2010) - The US
3.4 Acne Therapeutics Market Forecast (2010-2018) - The US
3.5 Acne Therapeutics Market Size (2005-2010) - France
3.6 Acne Therapeutics Market Forecast (2010-2018) - France
3.7 Acne Therapeutics Market Size (2005-2010) - Germany
3.8 Acne Therapeutics Market Forecast (2010-2018) - Germany
3.9 Acne Therapeutics Market Size (2005-2010) - Italy
3.10 Acne Therapeutics Market Forecast (2010-2018) - Italy
3.11 Acne Therapeutics Market Size (2005-2010) - Spain
3.12 Acne Therapeutics Market Forecast (2010-2018) - Spain
3.13 Acne Therapeutics Market Size (2005-2010) - The UK
3.14 Acne Therapeutics Market Forecast (2010-2018) - The UK
3.15 Acne Therapeutics Market Size (2005-2010) - Japan
3.16 Acne Therapeutics Market Forecast (2010-2018) - Japan
3.17 Drivers and Barriers for the Acne Therapeutics Market
3.17.1 Drivers for the Acne Therapeutics Market
3.17.2 Barriers for the Acne Therapeutics Market
3.18 Opportunity and Unmet Need
3.19 Key Takeaway

4 Acne Therapeutics - Competitive Assessment
4.1 Overview
4.2 Strategic Competitor Assessment
4.3 Product Profile for the Major Marketed Products in the Acne Therapeutics Market
4.3.1 Solodyn (minocycline)
4.3.2 Epiduo (BPO and adapalene)
4.3.3 Duac (clindamycin phosphate and BPO)
4.3.4 Tazorac (tazarotene)
4.3.5 Ziana (clindamycin phosphate and tretinoin)
4.3.6 Differin (adapalene)
4.3.7 Benzaclin (BPO and clindamycin phosphate)
4.3.8 Doryx (doxycycline hyclate)
4.4 Key Takeaway

5 Acne Therapeutics - Pipeline Assessment
5.1 Overview
5.2 Strategic Pipeline Assessment
5.3 Acne Therapeutics - Pipeline Analysis by Clinical Phase of Development
5.3.1 Acne Therapeutics - Phase III and Regulatory Filed Clinical Pipeline
5.3.2 Acne Therapeutics - Phase II Clinical Pipeline
5.3.3 Acne Therapeutics - Phase I Pipeline
5.3.4 Acne Therapeutics -Pre-clinical and Discovery Phase Pipeline
5.4 Acne Therapeutics - Pipeline by Mechanism of Action
5.5 Technology Trends Analytical Framework
5.6 Acne Therapeutics - Most Promising Drugs in Clinical Development
5.7 Other Most Promising Drugs in Clinical Development
5.7.1 Avugane
5.7.2 CB-03-01
5.7.3 JNJ 10229570-AAA
5.7.4 CIP-isotretinoin
5.7.5 E-0301
5.7.6 SPHD420
5.7.7 Recently Approved Products for the Treatment of Acne
5.8 Key Takeaway

6 Acne Therapeutics - Clinical Trials Mapping
6.1 Clinical Trials by Region/Country (The US, EU5 and Japan)
6.2 Clinical Trials by Phase of Clinical Development
6.3 Clinical Trials by Trial Status
6.4 Prominent Sponsors
6.5 Clinical Trials by Sponsors
6.6 Top Companies Participating in Acne Therapeutics Clinical Trials

7 Acne Therapeutics - Strategic Assessment
7.1 Key Events Impacting the Future Market
7.2 Future Market Competition Scenario

8 Acne Therapeutics - Future Players
8.1 Introduction
8.2 Company Profiles
8.2.1 Galderma
8.2.2 GlaxoSmithKline plc
8.2.3 Elorac, Inc.
8.2.4 Johnson & Johnson
8.2.5 TopoTarget A/S
8.2.6 Sinclair Pharma Plc
8.3 Other Companies in the Acne Therapeutics Market
8.4 Key Takeaway

9 Acne Therapeutics - Licensing & Partnership Deals

10 Acne Therapeutics - Appendix
10.1 Market Definitions
10.2 Abbreviations
10.3 Methodology
10.3.1 Coverage
10.3.2 Secondary Research
10.3.3 Forecasting
10.3.4 Primary Research
10.3.5 Expert Panel Validation
10.4 Contact Us
10.5 Disclaimer
10.6 Bibliography

1.1 List of Tables

Table 1: Grades of Acne on the Basis of Severity
Table 2: Characteristics of Various Grades of Acne
Table 3: Types and Characteristics of Acne
Table 4: Global Alliance Algorithm to Improve Outcomes in Acne
Table 5: Treatment Options Available for Acne
Table 6: Acne Therapeutics Market, Global, Revenue ($m), 2005-2010
Table 7: Acne Therapeutics Market, Global, Forecast ($m), 2010-2018
Table 8: Acne Therapeutics Market, The US, Revenue ($m), 2005-2010
Table 9: Acne Therapeutics Market, The US, Forecast ($m), 2010-2018
Table 10: Acne Therapeutics Market, France, Revenue ($m), 2005-2010
Table 11: Acne Therapeutics Market, France, Forecast ($m), 2010-2018
Table 12: Acne Therapeutics Market, Germany, Revenue ($m), 2005-2010
Table 13: Acne Therapeutics Market, Germany, Forecast ($m), 2010-2018
Table 14: Acne Therapeutics Market, Italy, Revenue ($m), 2005-2010
Table 15: Acne Therapeutics Market, Italy, Forecast ($m), 2010-2018
Table 16: Acne Therapeutics Market, Spain, Revenue ($m), 2005-2010
Table 17: Acne Therapeutics Market, Spain, Forecast ($m), 2010-2018
Table 18: Acne Therapeutics Market, The UK, Revenue ($m), 2005-2010
Table 19: Acne Therapeutics Market, The UK, Forecast ($m), 2010-2018
Table 20: Acne Therapeutics Market, Japan, Revenue ($m), 2005-2010
Table 21: Acne Therapeutics Market, Japan, Forecast ($m), 2010-2018
Table 22: Side-Effects Associated with the Marketed Products Available for the Treatment of Acne
Table 23: Acne Therapeutics Market, Phase III and Regulatory Filed Pipeline, 2011
Table 24: Acne Therapeutics Market, Phase II Pipeline, 2011
Table 25: Acne Therapeutics Market, Phase I Pipeline, 2011
Table 26: Acne Therapeutics Market, Pre-clinical and Discovery Phase Pipeline, 2011
Table 27: Acne Therapeutics Market, Global, Most Promising Drugs in Clinical Development, 2011
Table 28: Recently Approved Products for the Treatment of Acne
Table 29: Acne Therapeutics, Global, Clinical Trials, 2011
Table 30: Acne Therapeutics, Global, Clinical Trials by Phase, 2011
Table 31: Acne Therapeutics, Global, Clinical Trials by Status of Development, 2011
Table 32: Acne Therapeutics, Global, Prominent Sponsors, 2011
Table 33: Acne Therapeutics, Global, Overall Sponsors, 2011
Table 34: Acne Therapeutics, Global, Top Ten Companies by Phase, 2011
Table 35: Galderma - Pipeline, 2011
Table 36: GlaxoSmithKline - Pipeline, 2011
Table 37: Elorac, Inc. - Pipeline, 2011
Table 38: Johnson & Johnson - Pipeline, 2011
Table 39: TopoTarget A/S - Pipeline, 2011
Table 40: Sinclair Pharma Plc - Pipeline, 2011
Table 41: Other Companies in the Acne Therapeutics Market
Table 42: Acne Therapeutics, Global, Deals - 2011

1.2 List of Figures

Figure 1: Symptoms of Acne
Figure 2: Graphic Presentation of a Microcomedo
Figure 3: Graphic Presentation of a Closed Comedo (Whitehead)
Figure 4: Graphic Presentation of an Open Comedo (Blackhead)
Figure 5: Graphic Presentation of a Papule
Figure 6: Graphic Presentation of a Pustule
Figure 7: Types of Acne
Figure 8: Graphic Presentation of a PSU
Figure 9: Implications of Acne
Figure 10: Acne Therapeutics Market, Global, Revenue ($m), 2005-2010
Figure 11: Acne Therapeutics Market, Global, Forecast ($m), 2010-2018
Figure 12: Acne Therapeutics Market, The US, Revenue ($m), 2005-2010
Figure 13: Acne Therapeutics Market, The US, Forecast ($m), 2010-2018
Figure 14: Acne Therapeutics Market, France, Revenue ($m), 2005-2010
Figure 15: Acne Therapeutics Market, France, Forecast ($m), 2010-2018
Figure 16: Acne Therapeutics Market, Germany, Revenue ($m), 2005-2010
Figure 17: Acne Therapeutics Market, Germany, Forecast ($m), 2010-2018
Figure 18: Acne Therapeutics Market, Italy, Revenue ($m), 2005-2010
Figure 19: Acne Therapeutics Market, Italy, Forecast ($m), 2010-2018
Figure 20: Acne Therapeutics Market, Spain, Revenue ($m), 2005-2010
Figure 21: Acne Therapeutics Market, Spain, Forecast ($m), 2010-2018
Figure 22: Acne Therapeutics Market, The UK, Revenue ($m), 2005-2010
Figure 23: Acne Therapeutics Market, The UK, Forecast ($m), 2010-2018
Figure 24: Acne Therapeutics Market, Japan, Revenue ($m), 2005-2010
Figure 25: Acne Therapeutics Market, Japan, Forecast ($m), 2010-2018
Figure 26: Opportunity and Unmet Need in the Acne Therapeutics Market
Figure 27: Strategic Competitor Assessment of the Marketed Products in Acne Therapeutics, 2011
Figure 28: Acne Therapeutics Pipeline by Phase of Clinical Development, 2011
Figure 29: Acne Therapeutics Market, Global, Pipeline by Mechanism of Action (%), 2011
Figure 30: Technology Trends Analytics Framework, 2011
Figure 31: Technology Trends Analytics Frame Work - Description, 2011
Figure 32: Acne Therapeutics, Global, Clinical Trials by Country, 2011
Figure 33: Acne Therapeutics, Global, Clinical Trials by Phase (%), 2011
Figure 34: Acne Therapeutics, Global, Clinical Trials by Status of Development (%), 2011
Figure 35: Acne Therapeutics, Global, Prominent Sponsors (%), 2011
Figure 36: Acne Therapeutics, Global, Overall Sponsors (%), 2011
Figure 37: Acne Therapeutics, Global, Top Ten Companies by Phase, 2011
Figure 38: Acne Therapeutics Market, Drivers and Restraints, 2011
Figure 39: Implications for Future Market Competition in the Acne Therapeutics Market, 2011
Figure 40: Acne Therapeutics Market, Global, Future Players, 2011
Figure 41: GlobalData Market Forecasting Model